Dumitrescu Bianca, van Helden Svenjhalmar, ten Broeke Rene, Nieuwenhuijzen-Kruseman Arie, Wyers Caroline, Udrea Gabriela, van der Linden Sjef, Geusens Piet
Department of Internal Medicine, Subdivision of Rheumatology, University Hospital, Maastricht, The Netherlands.
BMC Musculoskelet Disord. 2008 Aug 5;9:109. doi: 10.1186/1471-2474-9-109.
The aetiology of osteoporotic fractures is multifactorial, but little is known about the way to evaluate patients with a recent clinical fracture for the presence of secondary osteoporosis. The purpose of this study was to determine the prevalence of contributors to secondary osteoporosis in patients presenting with a clinical vertebral or non-vertebral fracture. Identifying and correcting these contributors will enhance treatment effect aimed at reducing the risk of subsequent fractures. In a multidisciplinary approach, including evaluation of bone and fall-related risk factors, 100 consecutive women (n = 73) and men (n = 27) older than 50 years presenting with a clinical vertebral or non-vertebral fracture and having osteoporosis (T-score < or =-2.5) were further evaluated clinically and by laboratory testing for the presence of contributors to secondary osteoporosis. In 27 patients, 34 contributors were previously known, in 50 patients 52 new contributors were diagnosed (mainly vitamin D deficiency in 42) and 14 needed further exploration because of laboratory abnormalities (mainly abnormal thyroid stimulating hormone in 9). The 57 patients with contributors were older (71 vs. 64 yrs, p < 0.01), had more vertebral deformities (67% vs. 44%, p < 0.05) and a higher calculated absolute 10-year risk for major (16.5 vs. 9.9%, p < 0.01) and for hip fracture (6.9 vs. 2.4%, p < 0.01) than patients without contributors. The presence of contributors was similar between women and men and between patients with fractures associated with a low or high-energy trauma. We conclude that more than one in two patients presenting with a clinical vertebral or non-vertebral fracture and BMD-osteoporosis have secondary contributors to osteoporosis, most of which were correctable. Identifying and correcting these associated disorders will enhance treatment effect aimed at reducing the risk of subsequent fractures in patients older than 50 years.
骨质疏松性骨折的病因是多因素的,但对于如何评估近期发生临床骨折的患者是否存在继发性骨质疏松,人们了解甚少。本研究的目的是确定临床出现椎体或非椎体骨折的患者中继发性骨质疏松相关因素的患病率。识别并纠正这些相关因素将提高旨在降低后续骨折风险的治疗效果。采用多学科方法,包括评估骨骼和跌倒相关风险因素,对100例年龄超过50岁、出现临床椎体或非椎体骨折且患有骨质疏松症(T值≤ -2.5)的连续女性(n = 73)和男性(n = 27)进行了进一步的临床评估和实验室检测,以确定是否存在继发性骨质疏松的相关因素。27例患者中,34个相关因素先前已知;50例患者中,诊断出52个新的相关因素(主要是42例维生素D缺乏);14例因实验室异常(主要是9例促甲状腺激素异常)需要进一步检查。有相关因素的57例患者年龄更大(71岁对64岁,p < 0.01),椎体畸形更多(67%对44%,p < 0.05),计算得出的10年主要骨折绝对风险(16.5%对9.9%,p < 0.01)和髋部骨折绝对风险(6.9%对2.4%,p < 0.01)均高于无相关因素的患者。女性和男性之间以及低能量或高能量创伤相关骨折的患者之间,相关因素的存在情况相似。我们得出结论,超过半数出现临床椎体或非椎体骨折且骨密度为骨质疏松的患者存在继发性骨质疏松相关因素,其中大多数是可纠正的。识别并纠正这些相关疾病将提高旨在降低50岁以上患者后续骨折风险的治疗效果。